AR062305A1 - Metodos para mejorar la salud osea y la salud muscular - Google Patents

Metodos para mejorar la salud osea y la salud muscular

Info

Publication number
AR062305A1
AR062305A1 ARP070103526A ARP070103526A AR062305A1 AR 062305 A1 AR062305 A1 AR 062305A1 AR P070103526 A ARP070103526 A AR P070103526A AR P070103526 A ARP070103526 A AR P070103526A AR 062305 A1 AR062305 A1 AR 062305A1
Authority
AR
Argentina
Prior art keywords
health
improve
osea
methods
muscle
Prior art date
Application number
ARP070103526A
Other languages
English (en)
Inventor
Allan John Lepine
Bruce Alan Watkins
Kevin Mark Hannon
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of AR062305A1 publication Critical patent/AR062305A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L23/00—Soups; Sauces; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Un método para mejorar la salud osea y la salud muscular de un animal de companía; el método comprende la administracion al animal de companía de una composicion que comprende un componente de ácido graso en donde el componente de ácido graso comprende una relacion del ácido docosahexaenoico (DHA) al ácido eicosapentaenoico (EPA) de aproximadamente 3:1 a aproximadamente 25:1. La presente comprende además una composicion que comprende un componente de ácido graso que comprende ácido docosahexaenoico (DHA) y ácido eicosapentaenoico (EPA) en donde la relacion del ácido docosahexaenoico (DHA) al ácido eicosapentaenoico (EPA) es de aproximadamente 3:1 a aproximadamente 25:1.
ARP070103526A 2006-08-09 2007-08-09 Metodos para mejorar la salud osea y la salud muscular AR062305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83661106P 2006-08-09 2006-08-09

Publications (1)

Publication Number Publication Date
AR062305A1 true AR062305A1 (es) 2008-10-29

Family

ID=38924283

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103526A AR062305A1 (es) 2006-08-09 2007-08-09 Metodos para mejorar la salud osea y la salud muscular

Country Status (10)

Country Link
US (3) US20080076823A1 (es)
EP (1) EP2048970A2 (es)
JP (1) JP2009545308A (es)
CN (1) CN101500429A (es)
AR (1) AR062305A1 (es)
AU (1) AU2007282912A1 (es)
BR (1) BRPI0716022A2 (es)
CA (1) CA2660291C (es)
MX (1) MX2009001422A (es)
WO (1) WO2008018043A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CA2635907C (en) 2006-01-19 2016-10-04 Mary Kay, Inc. Compositions comprising kakadu plum extract or acai berry extract
CA2679215C (en) 2007-02-22 2015-11-24 Hill's Pet Nutrition, Inc. Compositions and methods for altering gene expression
CA2692394A1 (en) * 2007-07-06 2009-01-15 Seth J. Baum Fatty acid compositions and methods of use
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2704371A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
US20100316732A1 (en) * 2008-02-12 2010-12-16 Todd James Smith Beverage compositions for the promotion of joint health in companion animals
EP2320752A1 (en) * 2008-07-18 2011-05-18 Hill's Pet Nutrition, Inc. Method for enhancing the quality of life of a senior animal
JP2010105946A (ja) * 2008-10-29 2010-05-13 Nof Corp 筋タンパク質増強剤及びこれを含む医薬品または食品
BR112012004451A2 (pt) 2009-08-28 2016-03-22 Mary Kay Inc formulações para o cuidado com a pele"
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
DE102011000997A1 (de) * 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
EP2502506A1 (en) * 2011-03-21 2012-09-26 Abbott Laboratories Methods for improving bone health in infants using long chain polyunsaturated fatty acids
EP2705844B1 (en) 2011-04-13 2019-05-22 Ajinomoto Co., Inc. Nutritional composition
US20140037604A1 (en) * 2011-04-18 2014-02-06 Nestec S.A. Nutritional compositions comprising alpha-hydroxyisocaproic acid
WO2013094575A1 (ja) * 2011-12-21 2013-06-27 ユニ・チャーム株式会社 ペットフード
MX2017013715A (es) * 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
KR20180061081A (ko) * 2015-10-01 2018-06-07 디에스엠 아이피 어셋츠 비.브이. 애완동물 사료에 사용하기 위한 보충 물질
US11793579B2 (en) 2017-02-22 2023-10-24 Covidien Lp Integration of multiple data sources for localization and navigation
MX2020004739A (es) * 2017-11-17 2020-09-21 Hills Pet Nutrition Inc Composiciones que comprenden acidos grasos de cadena media y poliinsaturados omega-3.
CN108065037A (zh) * 2017-12-28 2018-05-25 嘉必优生物技术（武汉）股份有限公司 微生物发酵制备功能性饲料的方法及功能性饲料
CN110476844B (zh) * 2019-09-10 2021-12-31 南京农业大学 一种提高促进鱼体肌纤维发育和dha沉积的方法
CN117180328B (zh) * 2023-03-01 2024-03-22 再造再生健康科技(杭州)有限公司 一种促进胫骨生长发育的贴剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG22407A (en) * 2000-02-17 2003-01-29 Iams Company Method for improving bone modeling and chondrocyte functioning in growing canines
AU2002352726A1 (en) * 2001-11-15 2003-06-10 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
US20030194478A1 (en) * 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
US7410663B2 (en) * 2002-08-07 2008-08-12 Kao Corporation Oil or fat composition
JP4268473B2 (ja) * 2002-08-07 2009-05-27 花王株式会社 油脂組成物
SE0303513D0 (sv) * 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
WO2006074089A2 (en) * 2004-12-30 2006-07-13 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
EP1838169B1 (en) * 2004-12-30 2016-04-27 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a growing animal

Also Published As

Publication number Publication date
WO2008018043A2 (en) 2008-02-14
BRPI0716022A2 (pt) 2013-08-06
US20140377225A1 (en) 2014-12-25
AU2007282912A1 (en) 2008-02-14
CA2660291C (en) 2011-11-22
WO2008018043A3 (en) 2008-10-16
EP2048970A2 (en) 2009-04-22
CA2660291A1 (en) 2008-02-14
US20080076823A1 (en) 2008-03-27
JP2009545308A (ja) 2009-12-24
US20140343146A1 (en) 2014-11-20
MX2009001422A (es) 2009-02-19
CN101500429A (zh) 2009-08-05

Similar Documents

Publication Publication Date Title
AR062305A1 (es) Metodos para mejorar la salud osea y la salud muscular
BRPI0512528A (pt) uso de ácidos graxos poliinsaturados, composição nutricional, e, uso de uma composição
CO6470839A2 (es) Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas
HRP20130811T1 (en) Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia
NZ600167A (en) Concentrated therapeutic phospholipid compositions
IN2014DN06125A (es)
WO2011097276A8 (en) Methods and compositions for treating arthritis with docosahexaenoic acid
CR20120167A (es) Conjugados de niacina y ácidos grasos y sus usos
AR060041A1 (es) Mutantes de fad-2 y plantas ricas en oleico
WO2009091538A3 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
GB0314624D0 (en) Inflammatory disease treatment
CO6150156A2 (es) Esteres de dha y su utilizacion en el tratamiento y la prevencion de enfermedades cardiovasculares
AR075413A1 (es) Composiciones y metodo para usar aminopiridinas metodo para tratar la esclerosis multiple
WO2012049227A3 (en) Novel omega-3 and omega-6 fatty acid compositions and uses thereof
RU2012128503A (ru) Сбалансированные жировые композиции и их применение в жидких питательных композициях для энтерального питания
BR112014014130A2 (pt) tratamento ou redução de condições dentárias com ésteres de ascorbilo
GEP20146088B (en) Pharmaceutical composition including docosahexaenoic acid (dha) ester to be parenterally administered
GT200800235A (es) Formulacion de medicamento liquida
WO2008063772A3 (en) Resolvin d series and protectin d1 mitigate acute kidney injury
IT1392084B1 (it) Composizione immuno-nutrizionale
MX2019009337A (es) Eficacia a largo plazo de tratamiento de enfermedad hepatica con epa y dha.
ES2195764A1 (es) Aceite con propiedades terapeuticas.
CU23562A3 (es) Bioconversión estereoselectiva de dinitrilos alifáticos en ácidos cianocarboxílicos
ECSP12011709A (es) Conjugados de niacina y ácidos grasos y sus usos
TH124663B (th) สารเริมโภชนาการที่มีโพลีอันแซทตูเรท แฟตตี้ แอซิดสายโซ่ยาว

Legal Events

Date Code Title Description
FA Abandonment or withdrawal